Eribulina Zentiva

Eribulin Mesylate is a chemotherapy drug used to treat certain types of cancer. It works by slowing or stopping cancer cell growth. Learn more about its uses and effects.

Eribulin Mesylate is primarily used in the treatment of metastatic breast cancer and liposarcoma. It is administered intravenously and is designed to interfere with the growth and spread of cancer cells. Patients often wonder, 'What is Eribulin Mesylate used for?' It is typically prescribed for advanced stages of cancer that have not responded to other treatments.

Common effects of Eribulin Mesylate may include fatigue, nausea, and hair loss. Some patients also experience fever, constipation, and peripheral neuropathy. These effects can vary widely among individuals and are not experienced by everyone who takes the medication.

Eribulin Mesylate should be handled with care, as it is a potent chemotherapy agent. It is important to follow the advice of a healthcare professional regarding its use. Pregnant women and those planning to become pregnant should discuss the risks with their doctor.

Eribulin Mesylate may interact with other medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking. Alcohol and certain supplements may also interact with Eribulin Mesylate, so it is best to avoid them unless advised otherwise.